Cell & Gene

Cell and gene therapies are transforming modern medicine, offering life-changing treatments for conditions once deemed untreatable. However, delivering these therapies to a broader patient population requires overcoming complex manufacturing challenges.

Originally developed in academic labs, many of these therapies lack the infrastructure for consistent, scalable production. Contamination risks, process variability, and the intricacies of aseptic manufacturing necessitate a move toward advanced, automated solutions.

At Gencore Pharma, we bring deep expertise in pharmaceutical automation to help manufacturers transition from research-scale to commercial-scale production. With therapies often costing over £1 million per dose, automation becomes essential—not just for improving efficiency, but for ensuring precision, reducing cost, and addressing the growing shortage of skilled aseptic technicians.

Our tailored automation systems enable consistent, compliant, and scalable production—empowering the future of cell and gene therapy.